DJIA 18,200.75 -87.88 -0.48%
NASDAQ 4,978.34 -29.76 -0.59%
S&P 500 2,106.14 -11.25 -0.53%
market minute promo

Alkermes, Inc. (NASDAQ: ALKS)

72.08 0.61 (0.85%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALKS $72.11 0.90%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $71.75
Previous Close $71.47
Daily Range $70.07 - $72.28
52-Week Range $38.49 - $74.96
Market Cap $10.7B
P/E Ratio -340.33
Dividend (Yield) $0.00 (0.0%)
Volume 757,096
Average Daily Volume 1,485,576
Current FY EPS -$1.00

Sector

Healthcare

Industry

Drug Makers

Alkermes, Inc. (ALKS) Description

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Website: http://www.alkermes.com/

News & Commentary Rss Feed

This Could Be Game-Changing News in the Battle Against Multiple Sclerosis

Multiple sclerosis affects more than 400,000 people in the United States and around 2.5 million people globally. That's why this potentially game-changing study's results are so promising and important.

US Stock Futures Edge Higher Ahead Of Economic Data

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst B

Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog

How To Beat The Herd Mentality: Highline's Michael Higgins

Alkermes Falls on Pipeline News; Q4 Earnings Plunge Y/Y - Analyst Blog

Alkermes Falls on Pipeline News; Q4 Earnings Plunge Y/Y - Analyst Blog

Alkermes' (ALKS) CEO Rich Pops on Q4 2014 Results - Earnings Call Transcript

Jim Cramer: Use Share Weakness to Buy Alkermes for Its Drug Pipeline

Alkermes (ALKS) Q3 2015 Results - Earnings Call Webcast

Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms

Biotech Stock Roundup: Achillion Impresses with HCV Data, Regeneron 4Q Results Top Estimates - Analy

Biotech Stock Roundup: Achillion Impresses with HCV Data, Regeneron 4Q Results Top Estimates - Analyst Blog

Jim Cramer's Top Stock Picks: GM HAS SAVE ALKS

See More ALKS News...

ALKS's Top Competitors

ALKS $72.08 (0.85%)
Current stock: ALKS
AMGN $158.56 (-0.67%)
Current stock: AMGN
GILD $102.97 (-0.83%)
Current stock: GILD
BIIB $411.65 (-1.00%)
Current stock: BIIB